Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Operating Income (2024 - 2026)

Updated

Translational Development Acquisition (TDACU) recorded Operating Income of -$661,050 in Q2 2026, compared with -$221,127 a year earlier.

Analysis

Translational Development Acquisition (TDACU) Operating Income (2024 - 2026) Analysis & Trends

On a TTM basis, Translational Development Acquisition's Operating Income came in at -$1.32 million as of Jun 30, 2026; for FY2025, it was -$944,538.

  • Across earlier years, Operating Income came in at -$196,358 in FY2024 and -$485,550 in FY2023.
  • The Q2 2026 figure is the lowest quarterly Operating Income in data going back to Q2 2024.
  • Per Business Quant, the preceding three quarters came in at -$281,161 (Q1 2026), -$162,345 (Q4 2025) and -$213,658 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -661,050.00
Mar 31, 2026 -281,161.00
Dec 31, 2025 -162,345.00
Sep 30, 2025 -213,658.00
Jun 30, 2025 -221,127.00
Mar 31, 2025 -347,408.00
Dec 31, 2024 -133,390.00
Sep 30, 2024 -61,283.00
Jun 30, 2024 -1,685.00
API Access

Translational Development Acquisition Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=TDACU&period=max&api_key=YOUR_API_KEY